Breast cancer biomarkers, and a new clinical category for HER2 expression

Recent advances in treating breast cancer are reaching back to the past to the first known biomarker, human epidermal growth factor, to determine its value in treating patients

MLO Hot Clips Medical Laboratory Observer

Unleashing the power of anti-HER2 therapies in metastatic colorectal cancer: paving the way for a brighter future - ESMO Gastrointestinal Oncology

Oncology

Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer, Journal of Experimental & Clinical Cancer Research

What do we know about these breast cancer biomarkers HER2-Neu Estrogen Receptor Progesterone Receptor? - Enzo Life Sciences

IJMS, Free Full-Text

HER2 in Breast Cancer: ESMO Biomarker Factsheet

Determining breast cancer biomarker status and associated morphological features using deep learning

MLO LABline Daily - Feb 22nd, 2024

Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect